("Aurinia" or the "Company") (NASDAQ: AUPH) today announced that leading independent proxy advisor Glass, Lewis & Co. LLC ...

Studies of the consequences of BAFF overexpression have been complemented by studies investigating the effects of blocking either BAFF or both BAFF and APRIL (a proliferation inducing ligand, also ...

Vera Therapeutics, Inc.’s VERA share price has surged by 6.17%, which has investors questioning if this is right time to sell.

("Aurinia" or the "Company") (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder ...